Anti-PTEN/ 10q23del/ BZS monoclonal antibody
Anti-PTEN/ 10q23del/ BZS antibody for FACS & in-vivo assay
Go to PTEN/PTEN products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-T38257-Ab-1/ GM-Tg-hg-T38257-Ab-2 | Anti-Human PTEN monoclonal antibody | Human |
GM-Tg-rg-T38257-Ab-1/ GM-Tg-rg-T38257-Ab-2 | Anti-Rat PTEN monoclonal antibody | Rat |
GM-Tg-mg-T38257-Ab-1/ GM-Tg-mg-T38257-Ab-2 | Anti-Mouse PTEN monoclonal antibody | Mouse |
GM-Tg-cynog-T38257-Ab-1/ GM-Tg-cynog-T38257-Ab-2 | Anti-Cynomolgus/ Rhesus macaque PTEN monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-T38257-Ab-1/ GM-Tg-felg-T38257-Ab-2 | Anti-Feline PTEN monoclonal antibody | Feline |
GM-Tg-cang-T38257-Ab-1/ GM-Tg-cang-T38257-Ab-2 | Anti-Canine PTEN monoclonal antibody | Canine |
GM-Tg-bovg-T38257-Ab-1/ GM-Tg-bovg-T38257-Ab-2 | Anti-Bovine PTEN monoclonal antibody | Bovine |
GM-Tg-equg-T38257-Ab-1/ GM-Tg-equg-T38257-Ab-2 | Anti-Equine PTEN monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-T38257-Ab-1/ GM-Tg-hg-T38257-Ab-2; GM-Tg-rg-T38257-Ab-1/ GM-Tg-rg-T38257-Ab-2; GM-Tg-mg-T38257-Ab-1/ GM-Tg-mg-T38257-Ab-2; GM-Tg-cynog-T38257-Ab-1/ GM-Tg-cynog-T38257-Ab-2; GM-Tg-felg-T38257-Ab-1/ GM-Tg-felg-T38257-Ab-2; GM-Tg-cang-T38257-Ab-1/ GM-Tg-cang-T38257-Ab-2; GM-Tg-bovg-T38257-Ab-1/ GM-Tg-bovg-T38257-Ab-2; GM-Tg-equg-T38257-Ab-1/ GM-Tg-equg-T38257-Ab-2 |
Products Name | Anti-PTEN monoclonal antibody |
Format | mab |
Target Name | PTEN |
Protein Sub-location | Transmembrane Protein |
Category of antibody | FACS/Biofunctional Antibody, Therapeutics Target antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-PTEN benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | Products Developing | Multi-species PTEN/ 10q23del/ BZS VLP (virus-like particle) (Products Developing) |
ORF Viral Vector | vGMAD000006 | human PTEN Adenovirus particle |
ORF Viral Vector | pGMAD000006 | human PTEN Adenovirus plasmid |
ORF Viral Vector | vGMLV000452 | human PTEN Lentivirus particle |
ORF Viral Vector | pGMLV000452 | human PTEN Lentivirus plasmid |
ORF Viral Vector | pGMAD000353 | rat Pten Adenovirus plasmid |
ORF Viral Vector | pGMAAV000222 | Norway rat Pten AAV plasmid |
ORF Viral Vector | vGMAD000353 | rat Pten Adenovirus particle |
ORF Viral Vector | vGMAAV000222 | Norway rat Pten AAV particle |
Target information
Target ID | GM-T38257 |
Target Name | PTEN |
Gene ID | 5728,19211,50557,705121,403832,101091813,540786,100062388 |
Gene Symbol and Synonyms | 10q23del,2310035O07Rik,A130070J02Rik,B430203M17Rik,BZS,CWS1,DEC,GLM2,MHAM,Mmac,MMAC1,PTEN,PTEN1,PTENbeta,TEP1 |
Uniprot Accession | P60484,O54857,P60483 |
Uniprot Entry Name | PTEN_HUMAN,O54857_RAT,PTEN_CANLF |
Protein Sub-location | Transmembrane Protein |
Category | Therapeutics Target |
Disease | Cancer |
Gene Ensembl | ENSG00000171862 |
Target Classification | Tumor-associated antigen (TAA) |
The target: PTEN, gene name: PTEN, also named as 10q23del, BZS, CWS1, DEC, GLM2, MHAM, MMAC11, PTENbeta, TEP1, PTEN. This gene was identified as a tumor suppressor that is mutated in a large number of cancers at high frequency. The protein encoded by this gene is a phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase. It contains a tensin like domain as well as a catalytic domain similar to that of the dual specificity protein tyrosine phosphatases. Unlike most of the protein tyrosine phosphatases, this protein preferentially dephosphorylates phosphoinositide substrates. It negatively regulates intracellular levels of phosphatidylinositol-3,4,5-trisphosphate in cells and functions as a tumor suppressor by negatively regulating AKT/PKB signaling pathway. The use of a non-canonical (CUG) upstream initiation site produces a longer isoform that initiates translation with a leucine, and is thought to be preferentially associated with the mitochondrial inner membrane. This longer isoform may help regulate energy metabolism in the mitochondria. A pseudogene of this gene is found on chromosome 9. Alternative splicing and the use of multiple translation start codons results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2015].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.